1. Vimentin as a target for the treatment of COVID-19
   Zhenlin Li et al, 2020, BMJ Open Respiratory Research CrossRef
2. Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation?
   Mai-Britt Worm Ørntoft, 2018, Clinical Colorectal Cancer CrossRef
3. Vimentin: Regulation and pathogenesis
   Denise Paulin et al, 2022, Biochimie CrossRef
4. Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia
   Melissa B. Pappalardi et al, 2021, Nature Cancer CrossRef
5. A review of protein-protein interaction and signaling pathway of Vimentin in cell regulation, morphology and cell differentiation in normal cells
   Danial Hashemi Karoii et al, 2022, Journal of Receptors and Signal Transduction CrossRef
6. Epigenetics and personalized medicine of brain cancer
   George I. Lambrou, 2022, Epigenetics in Precision Medicine CrossRef
7. Immunohistochemical Expression of Epithelial-Mesenchymal Transition Markers in Early Gastric Cancer: Cancer Tissue versus Noncancer Tissue
   Hee Jae Jung et al, 2019, Clinical Endoscopy CrossRef
8. Detection of average methylation level of specific genes by binary-probe hybridization
   Xin-Ying Zhong et al, 2021, Talanta CrossRef
9. Vimentin Intermediate Filaments as Potential Target for Cancer Treatment
   Katerina Strouhalova et al, 2020, Cancers CrossRef